India  
 
NewsR.in

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

IndiaTimes Wednesday, 21 May 2025
Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
0
shares		ShareTweetSavePostSend
 

💡 newsR Knowledge: Other News Mentions

You Might Like


Related videos from verified sources

Massive NATO Scandal UNFOLDS | Raids, Arrests & International Corruption Allegations Shake Alliance [Video]

Massive NATO Scandal UNFOLDS | Raids, Arrests & International Corruption Allegations Shake Alliance

NATO faces a deepening crisis as a major corruption probe targets its support and procurement agency. Coordinated raids across six countries, including the U.S., led to multiple arrests over..

Credit: Oneindia     Duration: 03:09Published